Benchmark Electronics, Inc. (BHE) SEC Filings & Earnings Calls
EquiReason read 17 Benchmark Electronics, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-09-08 — Quarterly dividend of $0.17 per share declared, payable October 13, 2026. Routine declaration, no change in dividend policy indicated..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 2.4B
- P/E TTM
- 45.1
- Dividend yield
- 1.0%
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
8 Sep 20268-K · 8.01Quarterly dividend of $0.17 per share declared, payable October 13, 2026. Routine declaration, no change in dividend policy indicated.open
Figures in the filing · each found in the filing text
| quarterly dividend per share · Q3-2026 | $0.17 |
29 Jul 20268-K · 2.02Revenue $756M (+18% YoY), non-GAAP EPS $0.75 (+36% YoY), record bookings, raised FY revenue guidance to ~$3B.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $756M | +18% y/y |
| Non-GAAP Diluted EPS · Q2-2026 | $0.75 | +36% y/y |
| GAAP Diluted EPS · Q2-2026 | $0.55 | |
| Non-GAAP Gross Margin · Q2-2026 | 10.5% | |
| Non-GAAP Operating Margin · Q2-2026 | 5.2% | |
| Operating Cash Flow · Q2-2026 | $35M | |
| Free Cash Flow · Q2-2026 | $22M | |
| Semi-Cap Revenue · Semi-Cap · Q2-2026 | $223M | |
| Industrial Revenue · Industrial · Q2-2026 | $161M | |
| A&D Revenue · A&D · Q2-2026 | $111M |
Guidance
FY26 revenue raised to ~$3B (approx 13% growth); Q3 2026 revenue $755-795M; Q3 GAAP EPS $0.51-0.57; Q3 non-GAAP EPS $0.76-0.82
Raised FY revenue guidance to record $3B; Q3 guidance above Q2 actuals; strong demand and margin expansion
Risks flagged
Geopolitical and trade policy uncertainty could impact demand and supply chain
“Forward-looking statements mention geopolitical uncertainties, trade restrictions, tariffs, and retaliatory countermeasures”
Inflation and high interest rates may pressure costs and demand
“Forward-looking statements cite inflationary pressures and high interest rates as risks”
29 Jul 202610-QSales $756M (+18% y/y); Net income $20M (+1945% y/y); Gross profit $78M (+21% y/y)open
Figures in the filing · each found in the filing text
| Sales · Q2-2026 | $756M | +18% y/y |
| Net income · Q2-2026 | $20M | +1945% y/y |
| Gross profit · Q2-2026 | $78M | +21% y/y |
| Operating cash flow · H1-2026 | $82M | +185% y/y |
| Semi-Cap revenue · Semi-Cap · Q2-2026 | $223M | +17% y/y |
| AC&C revenue · AC&C · Q2-2026 | $127M | +71% y/y |
Risks flagged
Effective tax rate volatility
“Effective tax rate 30.8% vs 94.1% prior year, driven by geographic mix and discrete items.”
Inventory buildup
“Inventories increased to $544.3M from $482.5M at year-end, driven by raw materials.”
8 Jun 20268-K · 8.01Quarterly dividend per share $0.17open
Figures in the filing · each found in the filing text
| Quarterly dividend per share · Q2-2026 | $0.17 |
30 Apr 202610-QSales $677M (+7% y/y); Gross profit $69M (+10% y/y); Net income $13M (+257% y/y)open
Figures in the filing · each found in the filing text
| Sales · Q1-2026 | $677M | +7% y/y |
| Gross profit · Q1-2026 | $69M | +10% y/y |
| Net income · Q1-2026 | $13M | +257% y/y |
| Operating cash flow · Q1-2026 | $47M | +49% y/y |
| Capital expenditures · Q1-2026 | $18M | +340% y/y |
| Medical sector revenue · Medical · Q1-2026 | $128M | +24% y/y |
| AC&C sector revenue · AC&C · Q1-2026 | $105M | +41% y/y |
| Semi-Cap sector revenue · Semi-Cap · Q1-2026 | $191M | -2% y/y |
| A&D sector revenue · A&D · Q1-2026 | $120M | -2% y/y |
| Industrial sector revenue · Industrial · Q1-2026 | $133M | -3% y/y |
Risks flagged
Semi-Cap sector demand weakness
“Semi-Cap external revenue declined 2.3% YoY.”
Industrial sector demand weakness
“Industrial external revenue declined 2.5% YoY.”
Inventory build
“Inventories increased to $507.4M from $482.5M at year-end 2025.”
29 Apr 20268-K · 2.02Revenue $677M (+7% y/y); GAAP diluted EPS $0.36 (+260% y/y); Non-GAAP diluted EPS $0.58 (+12% y/y); Guidance: Full year revenue growth raised to 9-10% from mid-single-digit; Q2 revenue guidance $700-740M, non-GAAP EPS $0.65-0.71earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $677M | +7% y/y |
| GAAP diluted EPS · Q1-2026 | $0.36 | +260% y/y |
| Non-GAAP diluted EPS · Q1-2026 | $0.58 | +12% y/y |
| GAAP gross margin · Q1-2026 | 10.2% | |
| Non-GAAP gross margin · Q1-2026 | 10.3% | |
| GAAP operating margin · Q1-2026 | 3.2% | |
| Non-GAAP operating margin · Q1-2026 | 4.8% | |
| Operating cash flow · Q1-2026 | $47M | |
| Free cash flow · Q1-2026 | $29M | |
| Semi-Cap revenue · Semi-Cap · Q1-2026 | $191M | -2% y/y |
Guidance
Full year revenue growth raised to 9-10% from mid-single-digit; Q2 revenue guidance $700-740M, non-GAAP EPS $0.65-0.71
Full year revenue growth guidance raised to 9-10% from mid-single-digit; Q2 guidance implies sequential growth; margin improvement expected.
17 Apr 2026DEF 14ARevenue $2.66B (+0% y/y); Adjusted Operating Income $130M; Adjusted Inventory $550Mopen
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $2.66B | +0% y/y |
| Adjusted Operating Income · FY2025 | $130M | |
| Adjusted Inventory · FY2025 | $550M | |
| Net income · FY2025 | $25M | -59% y/y |
Risks flagged
2023 PSU failure indicates potential for missed long-term targets
“The Company issued no shares under the 2023 PSU three-year awards because the 2023 performance metrics were not achieved.” · word for word
CEO transition execution risk
“Mr. Moezidis became President and Chief Executive Officer effective March 31, 2026.”
16 Mar 20268-K · 8.01Benchmark Electronics declared a regular quarterly dividend of $0.17 per share, payable April 10, 2026.open
Figures in the filing · each found in the filing text
| Quarterly dividend per share · Q1-2026 | $0.17 |
24 Feb 202610-KRisks named: Tariff cost pass-through risk, Customer concentration riskopen
Risks flagged
Tariff cost pass-through risk
“If we are unable to fully pass on these costs or find new sources of components that we import, our results of operations and cash flows may be materially harmed.” · word for word
Customer concentration risk
“Sales to our ten largest customers represented 51%, 50% and 52% of our total sales in 2025, 2024 and 2023, respectively.” · word for word
24 Feb 20268-K · 5.02Annual base salary $900,000.00; Target cash bonus opportunity 115; Equity award value (customary annual) $2Mopen
Figures in the filing · each found in the filing text
| Annual base salary · FY2026 | $900000.00 | |
| Target cash bonus opportunity · FY2026 | 115.0% | |
| Equity award value (customary annual) · FY2026 | $3M | |
| Equity award value (additional on effective date) · Q1-2026 | $2M |
3 Feb 20268-K · 2.02Revenue $704M (+7% y/y); Diluted GAAP EPS $0.17 (-61% y/y); Diluted Non-GAAP EPS $0.71 (+16% y/y); Guidance: Q1 2026 revenue guidance $655-695M (midpoint $675M) vs Q4 2025 actual $704M; non-GAAP EPS guidance $0.53-0.59 (midpoint $0.56) vs Qearningsopen
Figures in the filing · each found in the filing text
| Revenue · Q4-2025 | $704M | +7% y/y |
| Diluted GAAP EPS · Q4-2025 | $0.17 | -61% y/y |
| Diluted Non-GAAP EPS · Q4-2025 | $0.71 | +16% y/y |
| Operating Cash Flow · Q4-2025 | $59M | |
| Free Cash Flow · Q4-2025 | $48M | |
| Revenue · FY2025 | $2.66B | +0% y/y |
| Diluted GAAP EPS · FY2025 | $0.68 | -59% y/y |
| Diluted Non-GAAP EPS · FY2025 | $2.40 | +5% y/y |
| Operating Cash Flow · FY2025 | $124M | |
| Free Cash Flow · FY2025 | $85M |
Guidance
Q1 2026 revenue guidance $655-695M (midpoint $675M) vs Q4 2025 actual $704M; non-GAAP EPS guidance $0.53-0.59 (midpoint $0.56) vs Q4 2025 actual $0.71
Guidance implies slight sequential revenue decline but stable margins; management expresses confidence in growth strategy and momentum.
Risks flagged
Semi-Cap segment revenue declined 14% YoY in Q4, indicating potential cyclical weakness in semiconductor capital equipment demand.
“Semi-Cap revenue $171M (Q4 2025) vs $198M (Q4 2024), -13.6% YoY.”
GAAP EPS significantly lower than non-GAAP due to restructuring and amortization charges; GAAP operating margin compressed to 2.9% from 4.3% YoY.
“GAAP operating margin 2.9% (Q4 2025) vs 4.3% (Q4 2024); GAAP EPS $0.17 vs $0.44.”
CEO transition introduces execution risk, though orderly succession plan is in place.
“CEO Jeff Benck transitioning out; David Moezidis named President.”
29 Dec 20258-K · 5.02Reported the departure of a director or principal officer (CEO/CFO change); filed financial statements and exhibits with this reportopen
Risks flagged
Loss of technology leadership; no successor named.
“CTO retired; no replacement announced.”
15 Dec 20258-K · 8.01Quarterly dividend per share $0.17open
Figures in the filing · each found in the filing text
| quarterly dividend per share · Q4-2025 | $0.17 |
5 Nov 202510-QBenchmark Electronics reported Q3 2025 revenue of $680.7M (+3.5% YoY) and net income of $14.3M (-7.2% YoY), with mixed segment performance.earningsopen
Figures in the filing · each found in the filing text
| Sales · Q3-2025 | $681M | +4% y/y |
| Gross profit · Q3-2025 | $68M | +2% y/y |
| Net income · Q3-2025 | $14M | -7% y/y |
| Diluted earnings per share · Q3-2025 | $0.39 | -7% y/y |
| A&D external revenue · Aerospace & Defense · Q3-2025 | $129M | +26% y/y |
| Medical external revenue · Medical · Q3-2025 | $126M | +18% y/y |
| Semi-Cap external revenue · Semi-Cap · Q3-2025 | $185M | -1% y/y |
| AC&C external revenue · AC&C · Q3-2025 | $88M | -20% y/y |
| Industrial external revenue · Industrial · Q3-2025 | $152M | +1% y/y |
| Cash and cash equivalents · 2025-09-30 | $285M |
Risks flagged
Restructuring execution risk
“Restructuring charges and other costs were $1.6M in Q3 2025 and $15.5M YTD, up from $0.8M and $5.6M in the prior year periods.”
Tax rate volatility
“Effective tax rate was 30.7% for Q3 2025 and 58.6% YTD, compared to 24.6% and 25.2% in the prior year periods, driven by discrete items including foreign withholding taxes.”
Segment concentration risk
“AC&C revenue declined 20% YoY in Q3 2025, indicating potential customer or end-market concentration risk.”
4 Nov 20258-K · 2.02Revenue $681M (+4% y/y); Non-GAAP Diluted EPS $0.62 (+9% y/y); GAAP Diluted EPS $0.39 (-7% y/y); Guidance: Q4 2025 revenue guidance $670-720M (midpoint $695M, +5.6% yoy); Non-GAAP EPS $0.62-0.68 (midpoint $0.65, +14% yoy at midpoint).earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2025 | $681M | +4% y/y |
| Non-GAAP Diluted EPS · Q3-2025 | $0.62 | +9% y/y |
| GAAP Diluted EPS · Q3-2025 | $0.39 | -7% y/y |
| GAAP Gross Margin · Q3-2025 | 10.0% | |
| Non-GAAP Gross Margin · Q3-2025 | 10.1% | |
| Cash Conversion Cycle (days) · Q3-2025 | 77 | -14% y/y |
| Semi-Cap Revenue · Semi-Cap · Q3-2025 | $185M | -2% y/y |
| Industrial Revenue · Industrial · Q3-2025 | $153M | +1% y/y |
| A&D Revenue · A&D · Q3-2025 | $129M | +27% y/y |
| Medical Revenue · Medical · Q3-2025 | $126M | +18% y/y |
Guidance
Q4 2025 revenue guidance $670-720M (midpoint $695M, +5.6% yoy); Non-GAAP EPS $0.62-0.68 (midpoint $0.65, +14% yoy at midpoint).
Q4 guidance above Q3 actuals; bookings momentum strong; enterprise AI ramping; management confident in growth trajectory.
Risks flagged
Gross margin compression yoy; GAAP gross margin down 10bps, Non-GAAP down 10bps.
“Gross Margin 10.0% (GAAP), 10.1% (Non-GAAP) vs 10.1% and 10.2% yoy.”
AC&C sector revenue declined 20% yoy; potential weakness in computing/communications end market.
“AC&C $88M 13% (vs $110M 17% yoy)”
Geopolitical and tariff risks could impact supply chain and customer demand.
“Geopolitical uncertainties including continuing hostilities and tensions, trade restrictions and sanctions, tariffs and retaliatory countermeasures...” · word for word
Benchmark Electronics, Inc. — questions
- What did Benchmark Electronics, Inc. file recently?
- 17 SEC filings in the last 12 months. Latest: 8-K on 2026-09-08 — Quarterly dividend of $0.17 per share declared, payable October 13, 2026. Routine declaration, no change in dividend policy indicated.
Every figure on this page comes from Benchmark Electronics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.